Carisma Therapeutics Inc.
CFO
2025-01-01–present
CFO
Carisma Therapeutics Inc.
Carisma Therapeutics Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Natalie McAndrew is recorded as CFO at Carisma Therapeutics Inc.. Carisma Therapeutics Inc. reported in an 8-K filed December 5, 2025 that Natalie McAndrew resigned as Vice President of Finance, Treasurer and Secretary, effective December 31, 2025. Carisma Therapeutics Inc. reported in an 8-K filed December 26, 2024 that Natalie McAndrew was appointed interim Vice President of Finance, effective January 1, 2025.
“On December 5, 2025, Natalie McAndrew notified the Company of her decision to resign as Vice President of Finance, Treasurer and Secretary of the Company, effective as of December 31, 2025.”
“The Board of Directors of the Company has appointed Ms. McAndrew as the interim Vice President of Finance, effective as of January 1, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Carisma Therapeutics Inc.
CFO
SEC 8-K
2025-01-01–present
Carisma Therapeutics Inc.
SEC 8-K
2025-01-01–present
Recorded roles and call appearances connecting this person to public companies.
Carisma Therapeutics Inc.
CFO
2025-01-01–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Carisma Therapeutics Inc.